An antitumor promoter from Moringa oleifera Lam.
Amelia P. Guevara(University of the Philippines Diliman), Hoyoku Nishino(Kyoto Prefectural University of Medicine), Carolyn Vargas(University of the Philippines Diliman), Yasuhiro Fujiwara(National Cancer Center Hospital East), Keiji Hashimoto(Kyoto Pharmaceutical University), Hiromu Sakurai(Kyoto Pharmaceutical University), Harukuni Tokuda(Kyoto Prefectural University of Medicine), Mutzuo Kozuka(Research Institute for Production Development), Takashi Maoka(Kyoto Pharmaceutical University), Yoshohiro Ito(Research Institute for Production Development)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
April 1, 1999
Cited by 404
Related Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice.
|PubMed|2000|334
The effect of quercetin on cell cycle progression and growth of human gastric cancer cells
|FEBS Letters|1990|320
Production of bioactive triterpenes by Eriobotrya japonica calli
|Phytochemistry|2002|292